CSTL Jun 2024 30.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 02:59PM EDT. Market open.
| Previous close | 0.5800 |
| Open | 0.2000 |
| Bid | 0.0000 |
| Ask | 0.6500 |
| Strike | 30.00 |
| Expiry date | 2024-06-21 |
| Day's range | 0.2000 - 0.5800 |
| Contract range | N/A |
| Volume | |
| Open interest | 610 |
Business WireCastle Biosciences to Present New Data at 2024 ASCO® Annual Meeting Highlighting Use of DecisionDx®-Melanoma to Identify Early-Stage Melanoma Patients at High Risk of Metastasis to the Central Nervous System to Prompt Use of Imaging Surveillance
FRIENDSWOOD, Texas, May 30, 2024--Castle will present new data related to its DecisionDx-Melanoma and DecisionDx-UM tests at the 2024 ASCO Annual Meeting, May 31-June 4, 2024.
Business WireNew Publication Shows DecisionDx®-SCC Identifies High-Risk Squamous Cell Carcinoma Patients Who Are Likely to Benefit from Adjuvant Radiation Therapy and Those Who Can Consider Deferring Treatment Based on Biological Risk of Metastasis
FRIENDSWOOD, Texas, May 29, 2024--Castle announced the publication of a study demonstrating the impact of the DecisionDx-SCC test in guiding adjuvant radiation therapy decision-making.
ZacksDoes Castle Biosciences (CSTL) Have the Potential to Rally 36.15% as Wall Street Analysts Expect?
The average of price targets set by Wall Street analysts indicates a potential upside of 36.2% in Castle Biosciences (CSTL). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
© 2024 Yahoo. All rights reserved.